Dexamethasone Causes Hypertension in Rats Even Under Chemical Blockade of Peripheral Sympathetic Nerves
Open Access
- 6 December 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 1305
Abstract
Synthetic glucocorticoids (GCs) are widely used to treat inflammatory conditions. However, chronic use of GCs can lead to hypertension. The cause of this undesired side effect remains unclear. Previously, we developed an in vivo rat model to study the mechanisms underlying hypertension induced by the chronic administration of the potent synthetic GC, dexamethasone (DEX) and found that the catecholamine biosynthetic pathway plays an important role. In the current study, we used this model to investigate the role of the adrenal medulla, renal nerves, and other peripheral sympathetic nerves in DEX-induced hypertension. After 5 days of baseline telemetric recording of mean arterial pressure (MAP) and heart rate (HR), rats were subjected to one of the following treatments: renal denervation (RDNX), adrenal medullectomy (ADMX), 6-hydroxydopamine (6-OHDA, 20 mg/kg, i.p.) to induce chemical sympathectomy, or a combination of ADMX and 6-OHDA. On day 11, the animals received vehicle (VEH) or DEX in drinking water for 7 days, with the latter causing an increase in MAP in control animals. ADMX and RDNX by themselves exacerbated the pressor effect of DEX. In the chemical sympathectomy group, DEX still caused a rise in MAP but the response was lower (ΔMAP of 6-OHDA/DEX < VEH/DEX, p = 0.039). However, when ΔMAP was normalized to day 10, 6-OHDA + DEX did not show any difference from VEH + DEX, certainly not an increase as observed in DEX + ADMX or RDNX groups. This indicates that sympathetic nerves do not modulate the pressor effect of DEX. TH mRNA levels increased in the adrenal medulla in both VEH/DEX (p = 0.009) and 6-OHDA/DEX (p = 0.031) groups. In the 6-OHDA group, DEX also increased plasma levels of norepinephrine (NE) (p = 0.016). Our results suggest that the activation of catecholamine synthetic pathway could be involved in the pressor response to DEX in animals even under chemical sympathectomy with 6-OHDA.Keywords
Funding Information
- American Heart Association
- U.S. Department of Veterans Affairs
This publication has 76 references indexed in Scilit:
- Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's DiseasePLOS ONE, 2012
- The glucocorticoid receptor in the distal nephron is not necessary for the development or maintenance of dexamethasone-induced hypertensionBiochemical and Biophysical Research Communications, 2010
- Identification of an Activator Protein-1-Like Sequence as the Glucocorticoid Response Element in the Rat Tyrosine Hydroxylase GeneMolecular Pharmacology, 2009
- A Critical Role for Vascular Smooth Muscle in Acute Glucocorticoid-Induced HypertensionJournal of the American Society of Nephrology, 2008
- EARLY RENAL DENERVATION PREVENTS DEVELOPMENT OF HYPERTENSION IN GROWTH‐RESTRICTED OFFSPRINGClinical and Experimental Pharmacology and Physiology, 2007
- ANTI‐OXIDANT EFFECTS OF ATORVASTATIN IN DEXAMETHASONE‐INDUCED HYPERTENSION IN THE RATClinical and Experimental Pharmacology and Physiology, 2006
- Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approachAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Contribution of vasopressin in dexamethasone-induced hypertension in rats.Hypertension, 1988
- Role of the renal nerves in one-kidney, one clip hypertension in rats.Hypertension, 1984
- Sympathetic nerves and adrenal medulla: contributions to cardiovascular-conditioned emotional responses in spontaneously hypertensive rats.Hypertension, 1983